JPY1,604.50
1.23% yesterday
Tokyo, Jul 18, 08:00 am CET
ISIN
JP3197600004
Symbol
4528
Sector
Industry

Ono Pharmaceutical Stock price

JPY1,599.50
+20.50 1.30% 1M
-25.00 1.54% 6M
-35.00 2.14% YTD
-656.00 29.08% 1Y
-2,329.50 59.29% 3Y
-1,348.00 45.73% 5Y
-1,332.50 45.45% 10Y
+569.48 55.29% 20Y
Tokyo, Closing price Fri, Jul 18 2025
-25.00 1.54%
ISIN
JP3197600004
Symbol
4528
Sector
Industry

Key metrics

Basic
Market capitalization
JPY762.9b
Enterprise Value
JPY699.2b
Net debt
positive
Cash
JPY210.4b
Shares outstanding
469.8m
Valuation (TTM | estimate)
P/E
15.0 | 11.3
P/S
1.6 | 1.5
EV/Sales
1.4 | 1.4
EV/FCF
9.4
P/B
1.0
Dividends
DPS
JPY80.00
Yield 1Y | 5Y
5.0% | 2.9%
Growth 1Y | 5Y
0.0% | 9.9%
Payout 1Y | 3Y
75.1% | 38.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
JPY486.9b | JPY523.9b
EBITDA
JPY86.6b | JPY114.9b
EBIT
JPY59.7b | JPY111.1b
Net Income
JPY50.0b | JPY67.4b
Free Cash Flow
JPY74.5b
Growth (TTM | estimate)
Revenue
-3.1% | 7.6%
EBITDA
-51.3% | 32.6%
EBIT
-62.6% | 86.0%
Net Income
-60.9% | 34.7%
Free Cash Flow
-17.1%
Margin (TTM | estimate)
Gross
69.6%
EBITDA
17.8% | 21.9%
EBIT
12.3%
Net
10.3% | 12.9%
Free Cash Flow
15.3%
Financial Health
Equity Ratio
73.5%
Return on Equity
6.4%
ROCE
6.5%
ROIC
6.8%
Debt/Equity
0.2
More
EPS
JPY106.5
FCF per Share
JPY158.5
Short interest
-
Employees
4k
Rev per Employee
JPY126.4m
Show more

Is Ono Pharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,009 stocks worldwide.

Ono Pharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Ono Pharmaceutical forecast:

1x Buy
6%
8x Hold
44%
9x Sell
50%

Analyst Opinions

18 Analysts have issued a Ono Pharmaceutical forecast:

Buy
6%
Hold
44%
Sell
50%

Financial data from Ono Pharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
486,871 486,871
3% 3%
100%
- Direct Costs 147,950 147,950
16% 16%
30%
338,921 338,921
10% 10%
70%
- Selling and Administrative Expenses 125,671 125,671
25% 25%
26%
- Research and Development Expense 149,866 149,866
34% 34%
31%
86,641 86,641
51% 51%
18%
- Depreciation and Amortization 26,894 26,894
48% 48%
6%
EBIT (Operating Income) EBIT 59,747 59,747
63% 63%
12%
Net Profit 50,047 50,047
61% 61%
10%

In millions JPY.

Don't miss a Thing! We will send you all news about Ono Pharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.

Head office Japan
CEO Gyo Sagara
Employees 3,853
Founded 1947
Website www.ono-pharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today